1035 Cambridge Street
Suite 18A
Cambridge, MA 02141
United States
212 582 1199
https://eternatx.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 8
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Ms. Sandra M. Gurrola | Principal Financial & Accounting Officer and Senior VP of Finance | 305.88k | N/D | 1967 |
Mr. Sanjeev Luther | CEO, President & Director | N/D | N/D | 1962 |
Ms. Dorothy J. Clarke | General Counsel & Director | N/D | N/D | 1966 |
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
La calificación ISS Governance QuickScore de Eterna Therapeutics Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.